During the last three months, 9 analysts shared their evaluations of Globe Life GL, revealing diverse outlooks from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 4 | 5 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 3 | 1 | 0 | 0 |
| 2M Ago | 0 | 1 | 3 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $94.33, a high estimate of $118.00, and a low estimate of $65.00. This current average has increased by 5.33% from the previous average price target of $89.56.
Interpreting Analyst Ratings: A Closer Look
The standing of Globe Life among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Nigel Dally | Morgan Stanley | Raises | Equal-Weight | $83.00 | $66.00 |
| Ryan Krueger | Keefe, Bruyette & Woods | Raises | Outperform | $118.00 | $110.00 |
| John Barnidge | Piper Sandler | Raises | Overweight | $106.00 | $105.00 |
| Mark Hughes | Truist Securities | Raises | Hold | $90.00 | $80.00 |
| Elyse Greenspan | Wells Fargo | Raises | Overweight | $108.00 | $105.00 |
| Nigel Dally | Morgan Stanley | Raises | Equal-Weight | $65.00 | $62.00 |
| Suneet Kamath | Jefferies | Raises | Hold | $88.00 | $85.00 |
| John Barnidge | Piper Sandler | Lowers | Overweight | $105.00 | $110.00 |
| Thomas Gallagher | Evercore ISI Group | Raises | In-Line | $86.00 | $83.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Globe Life. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Globe Life compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Globe Life's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Globe Life's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Globe Life analyst ratings.
Get to Know Globe Life Better
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
Key Indicators: Globe Life's Financial Health
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining Globe Life's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 8.58% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Globe Life's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 17.94% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Globe Life's ROE excels beyond industry benchmarks, reaching 5.03%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Globe Life's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.91% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.44, Globe Life adopts a prudent financial strategy, indicating a balanced approach to debt management.
The Significance of Analyst Ratings Explained
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
